Innovation to Solve the Healthcare Challenges of Today, Tomorrow, and Well Into the Future: RSNA 2023

With the global community facing a growing shortage of radiologists, the healthcare industry has been scrambling to reduce burnout and overwork among specialists in the field. GE HealthCare is leveraging innovation and artificial intelligence-enabled technologies to do just that — while also improving healthcare delivery and promoting positive outcomes for patients.

The company will feature more than 40 key innovations and AI-enabled solutions from its comprehensive portfolio at the Radiological Society of North America’s (RSNA) 2023 Annual Meeting, Nov. 26-30 in Chicago.


“With a history of innovation spanning more than a century, GE HealthCare operates at the center of the healthcare ecosystem and strives to help solve the healthcare challenges of today, tomorrow and well into the future,” said Peter Arduini, CEO of GE HealthCare. “We are committed to addressing radiology workforce challenges by focusing on the root causes of burnout, innovating to help clinicians feel more supported and helping providers deliver care when and where people need it. Through our smart devices, streamlined disease state focus and digital solutions, we’re helping to bring data together in the right place at the right time for providers, solving for inefficiencies in workflow, enabling precision care and helping improve patient outcomes.”

GE HealthCare’s showcase highlights technologies and solutions designed to support healthcare providers along clinical care pathways, including oncology, cardiology, and neurology, which allow clinicians to deliver a more personal, precise, and human-focused approach  from diagnosis to post-treatment. Those featured at RSNA23 enhance patient outcomes — and actively shape the future of healthcare — by advancing AI and deep learning, streamlining workflows, creating efficiencies, and leveraging strategic collaborations.


This year, we are celebrating several milestones within our different modalities. 30 years of ultrasound, 40 years of SIGNA MR and 50 years of MICT technology.

For the second year in a row, GE HealthCare topped the U.S. Food and Drug Administration (FDA) list of AI-enabled medical devices with the most 510(k) AI authorizations of any medtech company, with 58 to date. Among the AI-enabled and deep learning innovations being demonstrated at RSNA23 are: 

  • Theranostics Pathway Manager Tile on Command Center, aims to offer healthcare providers an easy-to-use application that simplifies the burdensome work of coordinating the oncology care pathway and identifying and tracking potential theranostics candidates – work that historically has been manual and tedious.
  • SIGNA Champion* is a brand new 1.5T scanner designed to offer true patient comfort and high-performance scans in a wide bore system, with access to premium technologies such as AIR Recon DL, Sonic DL and AIR Coils. It also has AI-enabled workflow features designed to support efficiency and image quality regardless of the experience level of the user.
  • Revolution Ascend Platform is a new CT solution with built-in scalability for onsite CT detector coverage upgrades that helps enable healthcare systems to invest in the clinical capabilities they need today, while enabling growth in the future – without replacing the gantry. This builds on the success of the similarly scalable Revolution Apex Platform, which will be adding the new ECG-less Cardiac** feature designed to help clinicians acquire images without the aid of the patient’s ECG signal/trace.
  • MyBreastAI Suite***, provides an all-in-one platform that integrates a comprehensive collection of AI tools that can seamlessly deploy AI to the breast imaging workflow. 
  • Critical Care Suite 2.1, expands triage capabilities with FDA clearance of new AI that detects and localizes a suspected pneumothorax (PTX) – providing immediate notification and overlay on-device for the presence or absence of PTX.
  • AI-enabled ultrasound solutions:    
  • Deep Learning portfolio: 
    • Effortless Recon DL, a portfolio of deep learning-based solutions that can help improve image quality and help better inform clinical decision-making, continues to expand with the development of True Enhance DL**** for CT, designed to further enhance its capabilities across multiple imaging practices.


GE HealthCare also offers next-generation solutions for streamlining workflows and increasing efficiency with innovations that include remote scan assistance, which provides real-time collaboration among all radiology teams; automatic patient positioning; and image management, offering simple and efficient reporting in clinical settings where time is of the essence.

“Health systems and providers are facing several core challenges in managing efficient workflows, including limited ability to adjust staffing, burnout among radiologists and technologists, and variations in imaging equipment across sites resulting in inefficient processes as well as training burden,” said Jan Makela, president and CEO of imaging at GE HealthCare. “We are uniquely positioned to help providers leverage imaging data across health care systems, connecting longitudinal data and layering it with analytics and AI to provide a full view into a patient’s journey, helping to solve diagnosis challenges and develop personalized approaches for better patient outcomes.”


Here are some of the efficiency innovations that will be showcased that span critical care pathways – including cardiology: 

  • Imaging 360 for Operations 2.0, is designed to improve radiology efficiency optimization.
  • Digital Expert Access is the first FDA 510(k)cleared device to enable remote patient scanning on GE HealthCare MR systems and helps accelerate care amid shortages of skilled technologists.
  • Effortless Workflow, a collection of CT, MR, and Molecular Imaging solutions launched as part of GE HealthCare’s Effortless Imaging portfolio, which intelligently automates time-consuming tasks to improve many aspects of imaging.
  • Allia IGS Pulse, designed to improve workflow for the diagnosis and treatment of cardiovascular disease in interventional cardiology.
  • CardioVisio for Atrial Fibrillation (AFib), a digital tool that assists clinicians in visualizing longitudinal data from multiple data sources, and drives evidence-based clinical decision support directed by up to date AFib guidelines.
  • Vscan Air SL, a handheld, wireless ultrasound imaging system to accelerate diagnoses and treatment decisions at the point of care. 

Find more information on what GE HealthCare is presenting at RSNA 2023.


* SIGNA Champion is 510(k) pending at the U.S. FDA. Not available for sale in the United States. Not yet CE marked. Not available in all regions.

** ECG-less Cardiac is 510(k) pending at the U.S FDA. Not available for sale in the United States. Not available in all regions. Exclusively available on GE HealthCare’s Revolution Apex Elite 160mm detector configuration.

*** MyBreastAI suite is a commercial offering that includes an AI platform optimized for Mammography, ProFound Dectection for DBT, SecondLook for 2D Mammography and PowerLook® Density Assessment. These three applications are provided by iCAD. MyBreastAI Suite is compatible with the latest versions of iCAD, Inc. as of November 14, 2023.

**** True Enhance DL is 510(k) pending at the U.S FDA. Not available for sale in the United States. Not available in all regions.